← board
ISCO
distress 0/10 · well-funded / low risk$0.25+47%today0% from 52w high
Revenue
pre-revenue
Liquidity
$1M
Runway
9.5 yrs
Shares 1y
0%
Price & events
+56.3% over 6M
CatalystRating changeDilutionFinancingdashed = today
+47.1%
1D
+19.0%
1W
+47.1%
1M
+78.6%
3M
+56.3%
6M
+38.9%
1Y
+150.0%
2Y
-58.3%
5Y
-37.5%
All
Overview
- Market Cap
- $2.00M
- Volume
- 18.63K
- 52 Week Range
- $0.12 – $0.25
- Total Shares
- 8.00M
- Float Shares
- 3.70M
- % Held by Insiders
- 53.77%
- % Held by Institutions
- 0.00%
- RVOL
- 2.55x
- Beta
- 0.00
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.